Clinical Trial Financial Management Framework

This document is a guide that outlines the complexities of clinical trial financial management, particularly focusing on the determination of fair market value (FMV) for investigator grants. It describes the challenges faced in pharmaceutical research and development, highlighting the increasing costs and complexities of clinical trials. The guide introduces the committed-anticipated-projected (CAP) principle as a framework for budgeting that adapts to evolving market conditions. It details how to evaluate historically committed costs, apply economic factors for anticipated adjustments, and project future shifts in economic and business factors. The document emphasizes the importance of using multiple data sources and statistical techniques to establish a defendable FMV. It also discusses the need for accurate budgeting to foster better relationships between sites and sponsors, ultimately aiming to improve financial decision-making in clinical trials. The CAP framework is presented as a revolutionary approach to budgeting that enhances accuracy and predictive capabilities.